BioWorld MedTech

Jan. 23, 2013

Selventa focuses on developing personalized care diagnostics

Selventa (Cambridge, Massachusetts) reported that it plans to introduce a new class of diagnostic test that would promote personalized healthcare technologies. Read More

Welch Allyn gains FDA clearance for iExaminer

Report from Europe: EU urged to act quickly on key med-tech regulations

Washington roundup: Covering OCT for verteporfin helps docs, not device makers

Financings roundup: MRI Interventions enters into securities purchase agreement

Agreements/contracts: Xifin uses PAML account management platforms

Deals roundup: Aetna in plan to sell Missouri Care to WHP

HIT roundup: New Mexico HIE to use Orion platform statewide

People in the News

Product Briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan. 13, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for January 13, 2025

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

BioWorld

The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...

Proteomics study explores how protein changes influence disease

BioWorld Science

Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

BioWorld

Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...